About deucravacitinib
TYK2 inhibitor
Used for
- Treats moderate-to-severe plaque psoriasis in adults who may benefit from systemic treatment or phototherapy.
Usual adult dose
6 mg by mouth once daily.
Common side effects
- Upper respiratory infections
- Headache
- Mouth sores
- Acne
Important warnings
- Serious infections can occur; tuberculosis screening is recommended before treatment.
- Avoid live vaccines during treatment.
- Rare serious infections, including herpes zoster, have been reported.
- Monitor for allergic reactions and liver enzyme changes.
Pregnancy
Human pregnancy information is limited; use only when potential benefit justifies potential risk.
Breastfeeding
It is unknown whether deucravacitinib passes into human milk; discuss risks and benefits with a healthcare professional.
Interactions
- Live vaccines may cause infection and should be avoided.
- Other immunosuppressive medicines may increase infection risk.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.